Overview of WHO Public Assessment Report (WHOPAR)

  HA110 - Lamivudine/Zidovudine - 150mg/300mg Film-coated tablets - GlaxoSmithKline - UK

• Part 1

• Part 2

• Part 7

Part 1 – Abstract
Part 2 – Presentation
Part 3 – Product Information Leaflet
Part 4 – Summary of Product Characteristics
Part 5 – Label
Part 6 – Discussion
Part 7 – Steps before Prequalification
Part 8 – Steps following Prequalification